XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
OPERATING ACTIVITIES    
Net loss $ (39,800,000) $ (907,600,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation expense 22,500,000 122,100,000
Gain (Loss) on Disposition of Assets (2,500,000) (1,400,000)
Accretion of discount on shareholders note (7,700,000) 0
Equity in earnings of ARO (4,300,000) (1,900,000)
Deferred income tax expense (benefit) (600,000) 900,000
Amortization, Net 1,600,000 (4,600,000)
Share-based compensation expense 3,400,000 3,800,000
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) (4,000,000.0) (4,000,000.0)
Amortization of debt issuance cost 200,000 0
Loss on impairment 0 756,500,000
Other 0 5,800,000
Changes in operating assets and liabilities 32,500,000 20,900,000
Contributions to pension plans and other post-retirement benefits 800,000 22,200,000
Net cash used in operating activities 500,000 (31,700,000)
INVESTING ACTIVITIES    
Additions to property and equipment 38,500,000 6,000,000.0
Net proceeds from disposition of assets 1,300,000 3,700,000
Net cash used in investing activities (37,200,000) (2,300,000)
FINANCING ACTIVITIES    
FINANCING ACTIVITIES 0 0
Effect of exchange rate changes on cash and cash equivalents and restricted cash 300,000 (100,000)
DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH (36,400,000) (34,100,000)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD 644,600,000 325,800,000
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD $ 608,200,000 $ 291,700,000